METHODS: Each of 33 patients took 250 mg gifitinib paros every day, discontinued when state of disease progressed, combined with nutritional supporting therapy, reducing intracranial pressure therapy, alleviating pain therapy, etc.

• 方法:33例患者均每日口服吉非替尼250mg,直到病情进展时停药。 同时选择性配合营养支持疗法、降低颅内压和止痛等治疗。